While almost undetectable or expressed at very low levels in normal tissues1, ERBB2 is overexpressed in several carcinomas, including breast cancers that display a more aggressive clinical course and a worst outcome compared to non ERBB2-positive BrCa4,5. This evidence concerns the gene ERBB2 and carcinoma.